Atrial flutter resident survival guide: Difference between revisions
Jump to navigation
Jump to search
| Line 45: | Line 45: | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree/end}} | {{familytree/end}} | ||
''Algorithm based on the 2003 ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias''<ref name="circ.ahajournals.org">{{Cite web | last = | first = | title = ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary | url = http://circ.ahajournals.org/content/108/15/1871 | publisher = | date = | accessdate = 15 August 2013 }}</ref> | |||
==References== | ==References== | ||
Revision as of 19:15, 15 August 2013
| File:Critical Pathways.gif |
|
Atrial flutter Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Atrial flutter resident survival guide On the Web |
|
American Roentgen Ray Society Images of Atrial flutter resident survival guide |
|
Risk calculators and risk factors for Atrial flutter resident survival guide |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Definition
Atrial flutter is an abnormal heart rhythm that occurs in the atria of the heart.
Causes
Life Threatening Causes
Life-threatening causes include conditions which result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Acute coronary syndromes
- Cardiomyopathy
- Congenital heart disease
- Hypertension
- Hyperthyroidism
- Mitral valve disease[1] [2]
Management
| Atrial flutter | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Unstable | Stable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CHF, shock, acute MI | Rate control: AV-nodal blockers | Conversion DC cardioversion Atrial pacing Pharmacological conversion | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DC cardioversion | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| If therapy for prevention of recurrences warranted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antiarrhythmic drugs | Catheter ablation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Algorithm based on the 2003 ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias[3]
References
- ↑ Gutierrez SD, Earing MG, Singh AK, Tweddell JS, Bartz PJ (2012). "Atrial Tachyarrhythmias and the Cox-maze Procedure in Congenital Heart Disease". Congenit Heart Dis. doi:10.1111/chd.12031. PMID 23280242. Unknown parameter
|month=ignored (help) - ↑ Granada, J.; Uribe, W.; Chyou, PH.; Maassen, K.; Vierkant, R.; Smith, PN.; Hayes, J.; Eaker, E.; Vidaillet, H. (2000). "Incidence and predictors of atrial flutter in the general population". J Am Coll Cardiol. 36 (7): 2242–6. PMID 11127467. Unknown parameter
|month=ignored (help) - ↑ "ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary". Retrieved 15 August 2013.
{{WikiDoc Sources}